Differences in initial benign prostatic hyperplasia management between primary care physicians and urologists.

Area of Science:

• Urology
• Primary Care Medicine
• Health Services Research

Background:

• Benign prostatic hyperplasia (BPH) is now a chronic condition requiring ongoing care.
• Primary care physicians (PCPs) are increasingly involved in BPH management.
• The impact of PCPs on BPH health service utilization is not well understood.

Purpose of the Study:

• To assess the impact of primary care physician involvement on the utilization of benign prostatic hyperplasia (BPH) related health services.
• To compare the practice styles of primary care physicians and urologists in managing BPH.
• To examine differences in diagnostic testing and medical therapy prescription between PCPs and urologists.

Main Methods:

• Retrospective cohort study using medical claims data (1997-2005).
• Identified incident cases of benign prostatic hyperplasia (BPH) and their initial treating physician.
• Used logistic regression to analyze the association between physician specialty and evaluative processes, and differences in medical therapy use.

Main Results:

• Urologists provided initial care for less than one-third of benign prostatic hyperplasia (BPH) cases.
• Urologists exclusively used office-based procedures and urodynamic tests.
• Urologists performed urinalysis and transrectal ultrasonography more frequently than PCPs (p <0.001).
• Patients seen by urologists were twice as likely to have laboratory studies (OR 2.03) and more likely to receive BPH medications (p <0.001).
• Urologists prescribed selective alpha-adrenergic blockers, 5alpha-reductase inhibitors, and combination therapy more often (p = 0.002).

Conclusions:

• Urologists exhibit a higher intensity practice style for benign prostatic hyperplasia (BPH) management compared to primary care physicians.
• Further investigation is required to correlate these practice style variations with patient clinical outcomes.